Labcorp Holdings is a diagnostic & research company located in North Carolina, United States, which is part of the Healthcare sector, and is traded under the ticker LH on the NYSE exchange.
Labcorp Holdings stock last closed at $270.38, down 0.32% from the previous day, and has increased 20.4% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.33 percentage points. Labcorp Holdings stock is currently +29.14% from its 52-week low of $209.38, and -4.62% from its 52-week high of $283.47.
At the moment, there are 83.1M shares of LH outstanding. The market capitalization of LH is $22.47B. In the last 24 hours, 370,000 LH shares were traded.
How to Buy Labcorp Holdings Stock
Not sure how to invest in Labcorp Holdings stock? Here's how.
Figure out where to buy Labcorp Holdings stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Labcorp Holdings stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Put funds into your brokerage account: Pick your payment method and add your information.
Research Labcorp Holdings stock: The Labcorp Holdings ticker symbol is LH. Is Labcorp Holdings stock a good investment? Should you buy shares of LH? How do LH's underlying business fundamentals look? Do top analysts think Labcorp Holdings is a good buy? Why has LH's stock price moved recently? (Hint: Our stock analysis website can help you understand if LH is a good stock to buy).
Make your LH buy order: Decide if you will purchase LH shares at the current market price or use a limit order to purchase LH stock at a particular price.
Track your LH position: Create a watchlist to the latest updates on your new investment in Labcorp Holdings stock.
Step 1: Figure out where to buy Labcorp Holdings stock
You will need an online brokerage account in order to access the NYSE market and buy LH stock.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal info so you are able to invest in LH stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Labcorp Holdings stock
After you have identified the best place to buy Labcorp Holdings stock, it's important to analyze their stock before you invest, so you truly wrap your head around the risk as well as the upside.
Labcorp Holdings Numbers
LH Price
$270.38
1w %
1.7%
1y %
20.4%
5y %
44%
P/E
29.61x
P/B
2.65x
P/S
1.67x
PEG
1.03x
Revenue
$13.48B
Earnings
$763.40M
Fore. Rev. Growth
4.71%
Fore. Earn. Growth
28.63%
Market Cap
$22.47B
Next Earnings
N/A
Next Dividend
Sep 11, 2025
Labcorp Holdings Overview
WallStreetZen was built to help average investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on LH's stock page.
Is LH stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge LH's intrinsic value.
Using relative valuations measures:
LH could be overvalued based on its P/E ratio of 29.61x, relative to Diagnostics & Research industry P/E ratio of 23.48x
LH could be undervalued based on its P/B ratio of 2.65x, relative to Diagnostics & Research industry P/B ratio of 3.86x
LH may be overvalued based on its PEG ratio of 1.03x
There are more short-term assets than short-term liabilities on the LH balance sheet.
LH earnings of $1.20B is not enough to cover its interest payments.
LH's operating cash flow of $1.69B allows it to safely service it's debt of $6.55B.
Total LH debt is lower than 5 years ago, relative to shareholder equity.
LH profit margin has gone up from 3.6% to 5.7% in the past year.
Negative Health Checks:
There are more long-term liabilities than short-term assets on the LH balance sheet.
LH has a relatively high debt to equity ratio of 1.13.
Do Wall Street analysts think it's a good time to buy LH stock
Out of 9 Wall Street analysts who give ratings on LH, the consensus analyst rating on LH is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest LH Analyst Forecasts
Jack Meehan, a top 6% analyst from Barclays maintains LH with a hold rating and raises their LH price target from $250.00 to $275.00, on Jun 25, 2025.
David Westenberg, a top 10% analyst from Piper Sandler maintains LH with a hold rating and raises their LH price target from $260.00 to $280.00, on May 6, 2025.
Jamie Clark, a top 46% analyst from Redburn Atlantic initiates coverage on LH with a strong buy rating and announces their LH price target of $276.00, on Apr 2, 2025.
Ralph Giacobbe, a bottom 10% analyst from Citigroup upgrades LH to a strong buy rating and raises their LH price target from $250.00 to $300.00, on Mar 4, 2025.
Last year, LH earnings were $763.40M. Over the past 5 year, LH's earnings have gone up by 19.73% per year. This was faster than the Diagnostics & Research industry average of 12%.
Last year, LH revenue was $13.48B. In the past five year, LH's revenue has increased by 3.28% per year. This was slower than the Diagnostics & Research industry average of 9.5%.
Labcorp Holdings pays a dividend of 0.8%, compared to the Diagnostics & Research industry's average dividend yield of 0.62%. If you owned $1,000 of LH stock, you would have received $7.99 last year.
Labcorp Holdings dividend payments have not consistently grown over the past decade but have remained stable.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your LH buy order
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly sufficient.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a given price, place a limit order.
Press the Open button and your broker will execute the order.
If you want additional info about buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Labcorp Holdings share?
As of Aug 15, 2025, it costs $270.38 to buy one share of Labcorp Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.37 shares of LH.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.